IRIS UniCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.212
EU - Europa 7.988
AS - Asia 7.188
SA - Sud America 1.384
AF - Africa 226
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 25
AN - Antartide 1
Totale 27.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.952
SG - Singapore 3.360
DE - Germania 2.018
CN - Cina 1.705
BR - Brasile 1.113
SE - Svezia 1.103
IT - Italia 976
FR - Francia 913
PL - Polonia 779
UA - Ucraina 683
VN - Vietnam 606
IE - Irlanda 384
GB - Regno Unito 347
IN - India 316
ID - Indonesia 256
FI - Finlandia 239
RU - Federazione Russa 196
HK - Hong Kong 160
TR - Turchia 136
CA - Canada 131
JP - Giappone 126
BD - Bangladesh 104
AR - Argentina 103
BE - Belgio 89
IQ - Iraq 79
MX - Messico 74
ZA - Sudafrica 68
NL - Olanda 44
IR - Iran 40
VE - Venezuela 38
PK - Pakistan 37
SA - Arabia Saudita 36
EC - Ecuador 33
ES - Italia 32
CO - Colombia 28
AU - Australia 27
CI - Costa d'Avorio 27
MA - Marocco 27
AT - Austria 26
KR - Corea 25
CL - Cile 22
CH - Svizzera 19
JO - Giordania 19
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
EG - Egitto 16
KE - Kenya 16
LT - Lituania 16
RO - Romania 15
TN - Tunisia 15
IL - Israele 14
NP - Nepal 14
PH - Filippine 14
AZ - Azerbaigian 13
DZ - Algeria 13
UY - Uruguay 13
BO - Bolivia 12
EU - Europa 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
DK - Danimarca 11
HN - Honduras 10
KG - Kirghizistan 10
PY - Paraguay 10
AL - Albania 9
GR - Grecia 9
JM - Giamaica 9
MY - Malesia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BG - Bulgaria 8
CR - Costa Rica 8
ET - Etiopia 8
LK - Sri Lanka 8
PA - Panama 8
PT - Portogallo 8
NO - Norvegia 7
OM - Oman 7
SN - Senegal 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
KH - Cambogia 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
LV - Lettonia 6
NG - Nigeria 6
TH - Thailandia 6
AM - Armenia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
AO - Angola 4
EE - Estonia 4
GE - Georgia 4
MM - Myanmar 4
SC - Seychelles 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GH - Ghana 3
KW - Kuwait 3
KZ - Kazakistan 3
Totale 26.993
Salva come PNG Salva come JPEG
Città #
Singapore 1.740
Chandler 1.287
Ashburn 1.000
San Jose 759
Warsaw 627
Ann Arbor 390
Jacksonville 389
Dearborn 371
Dublin 366
San Mateo 318
Beijing 305
Wilmington 288
Fairfield 273
Nanjing 250
Woodbridge 238
Jakarta 234
Ho Chi Minh City 198
New York 198
Lauterbourg 195
Houston 188
Los Angeles 180
Cattolica 178
Seattle 178
Boston 173
Hanoi 163
Munich 154
Hong Kong 150
Lawrence 140
Kraków 121
Milan 116
Hefei 107
Moscow 106
Frankfurt am Main 101
Rome 99
The Dalles 98
Tokyo 98
Dallas 95
São Paulo 94
Redwood City 92
Bremen 91
Chicago 90
Marseille 86
Cambridge 83
Izmir 83
Brussels 82
Nürnberg 81
Nanchang 76
Princeton 68
Buffalo 61
Kunming 61
Santa Clara 60
Helsinki 59
Boardman 57
Lancaster 57
Norwalk 57
Pune 56
Orem 51
Mountain View 50
Guangzhou 46
Hebei 46
London 43
Shenyang 43
Tianjin 39
University Park 37
Hangzhou 36
Shanghai 36
Redmond 35
Council Bluffs 34
Baghdad 33
Da Nang 33
Toronto 33
Paris 32
Falls Church 31
Johannesburg 30
Denver 29
Montreal 29
Chennai 28
Detroit 28
Phoenix 28
Jiaxing 27
Abidjan 26
Changsha 26
Nuremberg 26
Brooklyn 25
Rio de Janeiro 25
Zhengzhou 24
Atlanta 23
Fremont 23
San Francisco 23
Brasília 22
Jinan 22
Stockholm 22
Belo Horizonte 21
Dhaka 21
Kent 21
Leawood 21
Seoul 21
Turku 21
Andover 20
Augusta 20
Totale 14.575
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 438
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 432
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 356
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 344
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 341
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 314
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 304
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 263
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 257
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 244
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 243
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 224
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 224
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 220
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 213
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 209
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 209
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 207
Septic sacroiliitis: an uncommon septic arthritis 203
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 203
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 197
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 196
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 195
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 195
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 191
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 190
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 189
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 184
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 183
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 182
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 181
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 181
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 180
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 180
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 179
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 179
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 175
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 172
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 171
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 170
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 168
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 167
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 165
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 165
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 163
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 161
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 160
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 159
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 158
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 157
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 157
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 154
Preliminary classification criteria for the cryoglobulinaemic vasculitis 153
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 153
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 145
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 145
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 145
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 144
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 144
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 142
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 140
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 140
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 140
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 139
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 137
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 135
New therapeutic effects of cilostazol in patients with ischemic disorders. 134
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 133
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 132
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 132
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 131
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 131
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 130
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 129
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 127
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 127
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 126
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 126
Immune-Guided Therapy of COVID-19 126
Artrite reumatoide. Terapia 122
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 122
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 122
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 121
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 120
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 120
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 120
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 119
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 118
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 116
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 115
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 114
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 114
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 114
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 113
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 113
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 112
Polimialgia reumatica ed arterite temporale di Horton 112
Totale 17.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021412 0 0 0 0 0 0 0 0 0 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20253.291 73 93 294 118 323 87 75 165 526 293 633 611
2025/20268.256 1.516 288 485 871 1.513 467 1.622 390 518 586 0 0
Totale 27.411